Biopharmaceutical Third-party Logistics Market Forecast Highlights the Importance of Supply Chain Reliability

Biopharmaceutical Third-party Logistics Market Size, Forecast to 2034

The biopharmaceutical third-party logistics market covers specialized logistics services used to store, transport, and distribute biopharmaceutical products. These services include temperature-controlled warehousing, cold chain transportation, inventory management, packaging, and regulatory-compliant distribution. Third-party logistics providers support pharmaceutical manufacturers, biotechnology companies, and healthcare organizations in handling sensitive products such as vaccines, biologics, blood products, and cell and gene therapies.

The global biopharmaceutical third-party logistics market size was valued at USD 147.24 billion in 2025 and is projected to grow from USD 155.87 billion in 2026 to USD 245.82 billion by 2034, registering a CAGR of 5.86% during the forecast period from 2026 to 2034. North America dominated the market in 2025, accounting for 38.42% of global revenue.

Market Drivers

Expansion of the Biopharmaceutical Industry

The growing development and commercialization of biologics, vaccines, and advanced therapies increases demand for specialized logistics services. These products often require strict handling, storage, and transportation conditions to preserve quality and stability. Third-party logistics providers help manufacturers manage distribution networks and deliver sensitive medicines to healthcare facilities across multiple markets.

Increasing Outsourcing of Pharmaceutical Logistics

Pharmaceutical and biotechnology companies increasingly outsource logistics activities to reduce operational complexity and focus on core research and manufacturing operations. Third-party providers offer integrated transportation, warehousing, inventory management, and distribution services. Their established networks and specialized expertise help improve supply chain visibility and operational efficiency.

Advancements in Cold Chain Monitoring Technologies

The adoption of Internet of Things sensors, real-time shipment tracking, automated temperature monitoring, and digital warehouse management systems is improving pharmaceutical logistics. These technologies help providers monitor shipment conditions, identify potential disruptions, and maintain product integrity. Demand for advanced monitoring is particularly relevant to biologics, vaccines, and other temperature-sensitive therapies.

Market Challenges

High Costs of Temperature-Controlled Logistics

Cold chain transportation and storage require specialized vehicles, refrigeration systems, monitoring devices, and qualified facilities. These requirements increase operating expenses and can make logistics services costly, particularly for shipments involving strict temperature ranges or specialized handling procedures.

Regulatory Compliance and Quality Management

Biopharmaceutical logistics providers must comply with Good Distribution Practice requirements, product traceability standards, and country-specific pharmaceutical regulations. Maintaining consistent quality across international transportation networks requires documentation, validated processes, trained personnel, and regular audits. Regulatory differences between countries can further complicate cross-border distribution.

Risk of Product Damage During Transportation

Temperature deviations, handling errors, shipment delays, and equipment failures can affect the quality of sensitive biopharmaceutical products. Such disruptions may result in product losses, financial costs, and supply interruptions. Logistics providers must maintain reliable monitoring systems and contingency procedures to reduce these risks.

Market Segmentation

The biopharmaceutical third-party logistics market is segmented by supply chain and service type.

• By Supply Chain: Cold Chain, Non-cold Chain
• By Service Type: Transportation, Warehousing and Storage, Other Services
• By Region: North America, Europe, Asia Pacific, Middle East and Africa, Latin America

Regional Insights

North America Biopharmaceutical Third-party Logistics Market Analysis

North America dominated the market in 2025, accounting for 38.42% of global revenue. The region benefits from an established biopharmaceutical industry, advanced healthcare infrastructure, and demand for specialized pharmaceutical distribution. The presence of major logistics providers and investments in temperature-controlled supply chains further support regional leadership.

Europe Biopharmaceutical Third-party Logistics Market Analysis

Europe's market is supported by pharmaceutical manufacturing, cross-border medicine distribution, and established healthcare logistics infrastructure. Demand for temperature-controlled transportation and compliant storage services is increasing alongside the development of biologics and specialty medicines.

Asia Pacific Biopharmaceutical Third-party Logistics Market Analysis

Asia Pacific is projected to be the fastest-growing regional market. Expanding pharmaceutical manufacturing, rising healthcare demand, and increasing cross-border trade in medicines support regional growth. Investments in cold chain infrastructure and advanced logistics technologies also create opportunities for third-party providers.

Middle East and Africa Biopharmaceutical Third-party Logistics Market Analysis

The Middle East and Africa market is developing through investments in healthcare infrastructure, pharmaceutical distribution, and temperature-controlled storage facilities. Demand for reliable medicine transportation and improved access to specialized treatments creates opportunities for logistics providers.

Latin America Biopharmaceutical Third-party Logistics Market Analysis

Latin America's market benefits from pharmaceutical supply chain development and demand for reliable medicine distribution. Investments in warehousing, transportation networks, and cold chain capabilities can improve the movement of biologics and other temperature-sensitive products across the region.

Key Players Analysis

The biopharmaceutical third-party logistics market includes global transportation companies, pharmaceutical logistics specialists, and integrated supply chain providers. Competition is shaped by cold chain capabilities, geographic coverage, regulatory compliance, shipment visibility, and specialized storage infrastructure. Established providers continue to invest in temperature-controlled facilities and digital monitoring systems to support complex pharmaceutical distribution requirements.

Key industry participants include:

• FedEx
• DHL International GmbH
• SF Express
• United Parcel Service of America, Inc.
• C.H. Robinson Worldwide, Inc.
• Nippon Express
• DB Schenker
• Kuehne + Nagel
• XPO Logistics
• Kerry Logistics Network Limited

For Detailed Insights, Visit: https://straitsresearch.com/report/biopharmaceutical-third-party-logistics-market

About Us

Straits Research is a research and intelligence organization specializing in research, analytics, and advisory services, providing business insights and market research reports across diverse industries.

Contact Us

• Email: [email protected]
• U.S.: +1 646 905 0080
• U.K.: +44 203 695 0070